Skin Health Reimagined: Inside the BoF and Clinuvel Community Lunch at the Global Forum

The future of skin health is being shaped at the intersection of medicine, biotechnology, and longevity. At The Business of Beauty Global Forum 2026, investors from Goldman Sachs, L Catterton, and Bansk Beauty joined leaders from L'Oréal, Harrods, Space NK, and Unilever at a community lunch hosted by Business of Fashion and Clinuvel to explore exactly how these forces are redefining the industry.

Why This Forum Matters

The Business of Beauty Global Forum has established itself as a premier gathering for beauty industry leaders, investors, and innovators. The 2026 edition zeroed in on skin health — a category undergoing profound transformation as scientific advances open new frontiers in prevention, treatment, and personalisation.

The community lunch, co-hosted by Clinuvel — a biopharmaceutical company specialising in photoprotection and melanocortin-based therapies — brought together a uniquely cross-disciplinary group of stakeholders. The conversation bridged traditional beauty, pharmaceutical science, and venture capital, reflecting the increasingly blurred boundaries between these sectors.

Key Breakthroughs in Skin Health

Several emerging areas are driving the skin health revolution:

• Biotechnology-driven ingredients: Lab-grown peptides, fermented actives, and bioengineered compounds are replacing traditional botanical extracts, offering higher efficacy and sustainability.
• Longevity science: Research into cellular ageing and senolytics is influencing how brands position anti-ageing products — shifting from surface-level fixes to deep cellular repair.
• Medical aesthetics convergence: Prescription-grade skincare and minimally invasive treatments are merging with consumer beauty products, creating a continuum of care.
• Personalised diagnostics: AI-powered skin analysis and genetic testing are enabling hyper-targeted skincare regimens.

The Role of Investment Capital

The presence of Goldman Sachs, L Catterton, and Bansk Beauty at the forum underscores the significant capital flowing into skin health innovation. L Catterton, backed by LVMH, has been particularly active in beauty and wellness investments, while Goldman Sachs' interest signals Wall Street's recognition of skin health as a high-growth vertical.

Investors are increasingly looking beyond traditional beauty brands to biotech startups, medical device companies, and digital health platforms that address skin health from multiple angles. The convergence of health and beauty is creating new asset classes and investment theses.

Industry Leaders Weigh In

Representatives from L'Oréal, Harrods, Space NK, and Unilever shared perspectives on how the skin health evolution is reshaping retail, product development, and consumer engagement. Key themes included:

• Clinical credibility: Consumers increasingly expect evidence-based claims and dermatological validation.
• Omnichannel delivery: Skin health solutions must be accessible across clinical, retail, and digital channels.
• Sustainability integration: Biotech ingredients offer more sustainable alternatives to traditional sourcing, aligning with ESG commitments.

What This Means for the Beauty Industry

The discussions at the BoF-Clinuvel lunch point to a beauty industry in active transformation. Skin health is no longer a subcategory of cosmetics — it is becoming a standalone discipline that draws on pharmaceutical science, data analytics, and preventive medicine. Brands that adapt to this shift will capture growing consumer demand for products that deliver measurable, lasting results.

For retailers like Harrods and Space NK, the challenge is curating assortments that balance luxury positioning with clinical efficacy. For conglomerates like L'Oréal and Unilever, it means investing in R&D pipelines that blur the line between beauty and healthcare.

Frequently Asked Questions

1. What is the Business of Beauty Global Forum?
The Business of Beauty Global Forum is an annual event convened by Business of Fashion that brings together beauty industry leaders, investors, and innovators to discuss the most pressing trends and opportunities in the sector.

2. Why is Clinuvel involved in a beauty forum?
Clinuvel is a biopharmaceutical company with deep expertise in melanocortin-based therapies and photoprotection. Its involvement reflects the growing overlap between medical science and consumer beauty, particularly in advanced skin health.

3. How is longevity science changing skincare?
Longevity research is introducing new ingredients and approaches — such as senolytics and cellular repair compounds — that target ageing at the cellular level, moving beyond surface-level cosmetic solutions.

According to Business of Fashion.

For more on innovation and precision, see our guides: NH35 vs NH36 vs NH34 Movement Guide and First Seiko Mod Build: Order of Operations.